Litton Mark James

PRESIDENT and CEO at LONA; Chief Business Officer at ALDER BIOPHARMACEUTICALS INC

Sold, on record
$5.6M
Dollars the filings state
Form 4 sales
22
Latest Mar 4, 2026
Form 144 notices
2
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
2
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale LONANo plan
    Jan 5, 2024 2024

    Sold 4,820 shares at $2.91 ($14k)

    Litton Mark James, Chief Executive Officer

    No 10b5-1 planSold 3.2% of holdings ($434k position)144,397 shares leftFiling

  2. 2 Form 4 sale LONANo plan
    Sep 5, 2024 +244 days

    Sold 5,032 shares at $0.57 ($3k)

    Litton Mark James, President and CEO

    No 10b5-1 planSold 3.1% of holdings ($94k position)159,365 shares leftFollows a Form 144Filing

  3. 3 Form 144 notice LONANotice
    Sep 5, 2024 same day

    Filed to sell 5,032 shares ($1)

    Litton Mark James, Officer, Director

    No 10b5-1 planFiling

  4. 4 Form 144 notice LONANotice
    Jan 2, 2025 +119 days

    Filed to sell 25,107 shares ($14k)

    Litton Mark James, Officer, Director

    No 10b5-1 planFiling

  5. 5 Form 4 sale LONANo plan
    Jan 2, 2025 same day

    Sold 25,107 shares at $0.56 ($14k)

    Litton Mark James, President and CEO

    No 10b5-1 planSold 9.4% of holdings ($150k position)242,591 shares leftFollows a Form 144Filing

  6. 6 Form 4 sale LONAUnusual
    Jul 1, 2025 +180 days

    Sold 25,123 shares at $0.29 ($7k)

    Litton Mark James, President and CEO

    No 10b5-1 planSold 7.2% of holdings ($102k position)325,802 shares left5x usual sizeFiling

  7. 7 Form 4 sale LONANo plan
    Jan 2, 2026 +185 days

    Sold 2,586 shares at $6.88 ($18k)

    Litton Mark James, President and CEO

    No 10b5-1 planSold 6% of holdings ($299k position)40,828 shares left0.2x usual sizeFiling

  8. 8 Form 4 sale LONANo plan
    Mar 4, 2026 +61 days

    Sold 5,156 shares at $5.37 ($28k)

    Litton Mark James, PRESIDENT and CEO

    No 10b5-1 planSold 8.2% of holdings ($339k position)57,926 shares left0.3x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (24)

Form 144 notices and Form 4 sales by Litton Mark James
Source
Mar 4, 2026Mar 5, 2026LONAPRESIDENT and CEOForm 4 sale5,156$28k8.2%No planSEC
Jan 2, 2026Jan 5, 2026LONAPresident and CEOForm 4 sale2,586$18k6.0%No planSEC
Jul 1, 2025Jul 2, 2025LONAPresident and CEOForm 4 sale25,123$7k7.2%UnusualSEC
Jan 2, 2025Jan 3, 2025LONAPresident and CEOForm 4 sale25,107$14k9.4%No planSEC
Jan 2, 2025Jan 2, 2025LONAOfficer, DirectorForm 144 notice25,107$14kNoticeSEC
Sep 5, 2024Sep 5, 2024LONAOfficer, DirectorForm 144 notice5,032$1NoticeSEC
Sep 5, 2024Sep 5, 2024LONAPresident and CEOForm 4 sale5,032$3k3.1%No planSEC
Jan 5, 2024Jan 8, 2024LONAChief Executive OfficerForm 4 sale4,820$14k3.2%No planSEC
Jun 23, 2022Jun 24, 2022LONAChief Executive OfficerForm 4 sale7,960$21k5.8%Plan not statedSEC
Jun 1, 2018Jun 5, 2018ALDER BIOPHARMACEUTICALS INCChief Business OfficerForm 4 sale22,727$405k18.2%Plan not statedSEC
Nov 13, 2017Nov 15, 2017ALDER BIOPHARMACEUTICALS INCChief Business OfficerForm 4 sale16,519$178k14.2%Plan not statedSEC
Oct 16, 2017Oct 18, 2017ALDER BIOPHARMACEUTICALS INCChief Business OfficerForm 4 sale16,520$204k14.2%Plan not statedSEC
Jan 18, 2017Jan 20, 2017ALDER BIOPHARMACEUTICALS INCChief Business OfficerForm 4 sale1,498$35k1.5%Plan not statedSEC
Jan 9, 2017Jan 9, 2017ALDER BIOPHARMACEUTICALS INCChief Business OfficerForm 4 sale9,516$219k8.7%Plan not statedSEC
Oct 17, 2016Oct 19, 2016ALDER BIOPHARMACEUTICALS INCChief Business OfficerForm 4 sale6,000$165k18.8%Plan not statedSEC
Jun 13, 2016Jun 15, 2016ALDER BIOPHARMACEUTICALS INCChief Business OfficerForm 4 sale6,000$174k17.6%Plan not statedSEC
May 31, 2016Jun 1, 2016ALDER BIOPHARMACEUTICALS INCChief Business OfficerForm 4 sale25,000$751k25.1%UnusualSEC
Jan 4, 2016Jan 6, 2016ALDER BIOPHARMACEUTICALS INCChief Business OfficerForm 4 sale25,000$785k25.3%UnusualSEC
Oct 1, 2015Oct 5, 2015ALDER BIOPHARMACEUTICALS INCChief Business OfficerForm 4 sale7,500$242k9.3%Plan not statedSEC
Jul 1, 2015Jul 6, 2015ALDER BIOPHARMACEUTICALS INCChief Business OfficerForm 4 sale7,500$383k10.0%Plan not statedSEC
Jun 4, 2015Jun 8, 2015ALDER BIOPHARMACEUTICALS INCChief Business OfficerForm 4 sale25,000$1.1M25.0%UnusualSEC
Apr 1, 2015Apr 3, 2015ALDER BIOPHARMACEUTICALS INCChief Business OfficerForm 4 sale7,500$206k9.2%Plan not statedSEC
Jan 27, 2015Jan 28, 2015ALDER BIOPHARMACEUTICALS INCChief Business OfficerForm 4 sale7,500$211k8.4%Plan not statedSEC
Nov 20, 2014Nov 24, 2014ALDER BIOPHARMACEUTICALS INCChief Business OfficerForm 4 sale30,000$469k25.3%UnusualSEC